Biotech Leader Eyes Spinoff Amid Massive Sales Surge

Biotech Stock Plans Spinoff Amid Massive Sales Surge | Investor's Business DailyBREAKING: [Futures Fall; Google AI Spending Soars]---AnaptysBio (ANAB) cleared a trendline entry near 50 on Monday, according to IBD MarketSurge chart analysis tools. That. along with its turnaround third quarter, makes the biotech stock Tuesday's selection for IBD 50 Stocks To Watch. AnaptysBio stock is coming up the right side of a cup base with a buy point of 52.47 amid a drawn-out legal battle over…## Related news## AnaptysB ...